Meet Advisor Academy – A global online conference featuring the latest innovations, research, products and expertise in diabetes care technology – brought to you by the world leaders in the field of diabetes research.
President & CEO | Beyond Type 1
Sign up now to attend a live conference session or access past sessions
Live conference session will include a variety of formats: state-of-the-art lectures, case studies, product reviews, oral presentations and more. Attendees are welcome to prepare their questions and engage with the presenter over Q&A time.
With the rapid development of technologies and innovation in the world, it can be difficult to keep up with all technological and therapeutic advancements in the field. I invite you to join the Advisor Academy, where thought leaders, top researchers and medical innovators will share their expertise and enable you to stay on top of the exciting developments and breakthrough technologies in our field."
Dr. Revital Nimri, Program Director
Director of the Scientific and Technology Diabetes Service, Diabetes Technology Center at the Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel.
Revital Nimri (MD) graduated from Technion, Haifa, Israel in 1991 and specialized in pediatrics and then in pediatric endocrinology in 2001-2006 at the Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel. She is a pediatrician and senior endocrinologist taking care of patients with various endocrine disorders including patients with type 1 diabetes, monogenic diabetes and neonatal diabetes. Her research interests include basic and clinical research in pediatric diabetology with special emphasis on new insulins, insulin pumps, glucose sensors and the artificial pancreas. She is currently the Director of the Scientific and Technology Diabetes Service and Diabetes Technology Center at Schneider. She has a 20-years track record of expertise in clinical diabetes and in the last decade she has been focusing solely on new and innovative technologies for the treatment of type 1 diabetes. Dr. Nimri is active in both development and clinical testing of automated insulin delivery systems and decision support systems. She had a key role in the initiation, the development process and design of the MD-Logic artificial pancreas, a unique clinical driven technology based on a fuzzy logic control algorithm. The MD-Logic was the first closed-loop system to be tested at home. She received academic and professional awards for clinical research in pediatric endocrinology and a special award for contribution to the research in diabetes mellitus from the Israel Diabetic Association. Currently, she is principal investigator of several large projects dedicated to the development and clinical testing in multi-center, multinational studies of closed-loop system and different advisory software for the treatment and management of type 1 diabetes. Dr. Nimri’s research is funded by the National Institute of Health, the Juvenile Diabetes Research Foundation, Helmsley charitable trust and Industrial partners.
Papers: published papers on pediatric perspective on Insulin pumps, sensors, therapy advisor and artificial pancreas.
Director of the Scientific and Technology Diabetes Service, Diabetes Technology Center at the Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
Department of Pediatric Endocrinology, Diabetes and Metabolism, University Children’s Hospital, University Medical Centre Ljubljana, Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia
Department of Diabetes, Endocrinology, and Clinical Research, Children’s and Youth Hospital Auf der Bult, Hannover Medical School, Hannover, Germany
University of Washington School of Medicine, Seattle, WA, USA
Barbara Davis Center for Diabetes and University of Colorado School of Medicine, Aurora, Colorado, USA
Bournemouth University, Bournemouth, UK
BHR Ltd., Portsmouth, UK
Professor of Pediatrics (Endocrinology) and Health Research and Policy (Epidemiology) at the Lucile Salter Packard Children’s Hospital and at the Stanford University Medical Center
David Klonoff, Irl Hirsch, Roy Beck and Lori Laffel
David Klonoff – Real World evidence in clinical trials.
Irl Hirsch – A Real World look at time in range (TIR) and glucose management indicator (GMI).
Roy Beck – Time in Range and diabetes complications.
Lori Laffel – Approaches to increasing glucose time-in-range in the pediatric age group.
Professor, York University & Senior Scientist at LMC Diabetes & Endocrinology
Richard M. Bergenstal
Executive Director, Clinical Professor | Saint Louis Park, Minnesota
Endocrine Clinical Pharmacy Specialist, CGM Program Coordinator at Cleveland Clinic, Ohio
Do you have a specific topic you’d like us to cover?
Want to recommend a speaker for a conference session?
Or maybe nominate yourself?
We want to hear from you!